Boston Scientific reported that electrophysiology sales grew 172% in Q4 2024, driven by an uptake of its Farapulse pulsed field ablation (PFA) system. Revealing its Q4 and full-year results ...

Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

as the narrow-moat-rated Boston Scientific largely met our full-year expectations, and our 2025 projections remain bounded by management's outlook. We expect the Farapulse franchise for atrial ...

Boston Scientific Corp. recently received CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview mapping software to be used with its Farapulse pulsed field ablation (PFA) ...

As pulsed field ablation transformed the electrophysiology market over the last year, Boston Scientific Corp. emerged as the biggest winner by far. In its fourth quarter earnings call on Wednesday, ...

The Electrophysiology arm is expected to gain momentum on the sustained adoption of FARAPULSE PFA. Based on short-term price targets by 27 analysts, Boston Scientific's average target price is $ ...

Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.

Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted fourth ...